In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.VISIT NEW SITE
News from the world of biotech
3 minute read
Growing up, I never had any real interest in science or technology.
(A bit rich coming from the person bringing you this biotech-themed newsletter I admit, but it’s true.)
I was never any good at maths. And physics — forget about it.
I did have a passing interest in biology, but that was short-lived after a chemical mix up sent a spark from the test tube down the front of my school shirt, incinerating the birthmark on my chest. I don’t know if that says more about my inability as a scientist, or the lack of safety in schools in the 1980s.
Probably a bit of both. But I digress...
What I have developed as time has gone by is an interest in research and development for various cancers. Cancer has taken the lives of several family friends and I have a young niece currently in remission.
Heart disease and diabetes also run in the family. So I keep a keen eye on any progress made by biotech and medtech companies with regards to potential cures and preventions for a whole range of conditions.
Medical diagnostics innovator Rhythm Biosciences is in the process of preparing reagents for its ColoSTATTM blood test, which tests for colorectal cancer. Prescient Therapeutics is working in the field of breast cancer, bringing two novel cancer drugs to the table.
As we move forward to cover a broader church in this space on Finfeed, some of the companies will be ASX listed entities; others will be unlisted companies (which may not be suitable for retail investors) working for the greater good to eradicate various diseases.
We’ll also take a look at what’s happening in the various sectors that make up the biotech landscape including agricultural biotechnology, plant biotechnology, nutrient, industrial and more... and we’ll link you to articles such as How Plant Biotechnology Can Give Us Better Food and Medicines.
The importance of being Biotech
Put simply, biotech is technology based on biology. The highschool kid in me shudders at the thought. The adult in me says No, no — keep going. I want to hear more about it.
Here's another definition from USC News: “Biotech uses the cellular and molecular processes that occur in living organisms to create products that treat diseases, improve agriculture and reduce our environmental footprint.
“Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.” (Read the full USC article here.)
The importance of biotech shouldn’t be underestimated, considering it can lead to tailor-made cures, eradication of diseases, better diagnostics and an overall healthier society.
(Maybe it could even regenerate my birthmark. A man can hope!)
I'm looking forward to bringing you a weekly rundown of my findings and thoughts on this exciting sector — so stay tuned.
This article is General Information and contains only some information about some elements of one or more financial products. It may contain; (1) broker projections and price targets that are only estimates and may not be met, (2) historical data in terms of earnings performance and/or share trading patterns that should not be used as the basis for an investment as they may or may not be replicated. Those considering engaging with any financial product mentioned in this article should always seek independent financial advice from a licensed financial advisor before making any financial decisions.